Company Overview

Update
Founded:
2007
Headquarters:
Philadelphia, PA
IPO:
Went Public on Jun 18, 2013
Stock:
NASDAQ:IRKO
Categories:
Biotechnology

Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.

Description

Update

In the short period since Iroko was founded in 2007, we have assembled a portfolio of proven pharmaceuticals, especially prescription pain medicines. Our goal has been to bring new life to these trusted products—new geographic markets, new indications, and new benefits through further development enabled by new technology.

We have already extended a distribution and sales network across more than 40 countries. And we have developed an industry-leading pipeline of nano-formulated lower-dose NSAIDs to address the need for new options in pain management.

Experience. Marketed products. A global presence. Innovation.

That’s Iroko. We’re an established company. And we’re hurrying to improve healthcare.

Board Members and Advisors (1)

Update

Funding Rounds (1) - $75M

Update

Investors (1)

Update
  • B1ce9d2887c930e2d5d82b64a7eebcb9

    OrbiMed Advisors

    OrbiMed is ahealthcare-dedicated investment firm, with approximately $5 billion in assets under..

Offices/Locations (1)

Update
  • Office

    One Kew Place

    150 Rouse Boulevard

    Philadelphia, PA 19112

    USA

Images (1)

Update
  • 0e8369e771b6f78e99d68fc93238b5b7